GIACOMINI, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 734
EU - Europa 371
AS - Asia 122
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.230
Nazione #
US - Stati Uniti d'America 731
IT - Italia 291
CN - Cina 109
SE - Svezia 30
FI - Finlandia 14
IN - India 12
DE - Germania 8
GB - Regno Unito 7
FR - Francia 5
ES - Italia 3
NL - Olanda 3
CH - Svizzera 2
HR - Croazia 2
IE - Irlanda 2
MX - Messico 2
PL - Polonia 2
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CA - Canada 1
MA - Marocco 1
PT - Portogallo 1
RS - Serbia 1
Totale 1.230
Città #
Padova 107
Fairfield 84
Chandler 80
Ashburn 54
Cambridge 53
Beijing 42
Houston 37
Seattle 37
Medford 33
Princeton 33
Wilmington 31
Ann Arbor 23
Woodbridge 23
Des Moines 19
San Diego 18
Malo 16
Helsinki 12
Boardman 11
Parma 10
Cagliari 8
Shenyang 8
Milan 7
Saviano 7
Jinan 6
Livorno 6
Rome 6
Vicenza 6
Duncan 5
Nanjing 5
Naples 5
Redwood City 5
Tivoli 5
Pune 4
Agordo 3
Amsterdam 3
Assemini 3
Bagnolo del Salento 3
Cabiate 3
Enna 3
Erandio 3
Mercato San Severino 3
Ogden 3
Torino 3
Verona 3
Acton 2
Atlanta 2
Aversa 2
Cadoneghe 2
Changsha 2
Columbus 2
Como 2
Corminboeuf 2
Dublin 2
Este 2
Guangzhou 2
Hefei 2
Lanzhou 2
Lappeenranta 2
Lodz 2
Martellago 2
Monopoli 2
Nanchang 2
New York 2
Nice 2
Norwalk 2
Pisa 2
Rockville 2
Roxbury 2
San Benedetto del Tronto 2
San Juan del Río 2
Silea 2
Sommacampagna 2
Terno d'Isola 2
Washington 2
Zagreb 2
Zhengzhou 2
Albignasego 1
Bagnaria Arsa 1
Bassano Del Grappa 1
Bologna 1
Borås 1
Brisbane 1
Corropoli 1
Dongguan 1
Florence 1
Genoa 1
Haikou 1
Hamburg 1
Hangzhou 1
Hebei 1
Hounslow 1
Jiaxing 1
Kunming 1
Lanciano 1
Las Vegas 1
London 1
Montesilvano Marina 1
Ningbo 1
Porto 1
Rabat 1
Totale 927
Nome #
IDENTIFICATION OF NEW PHARMACOLOGICAL TARGETS IN CHEMOTHERAPY RESISTANCE: FOCUS ON METABOLIC REPROGRAMMING 64
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 64
Metabolic Plasticity in Chemotherapy Resistance 56
Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH) 55
Plumbagin Induces Cell Cycle Arrest and Apoptosis in A431 Cisplatin-Resistant Cancer Cells 54
IDENTIFICAZIONE DI NUOVI BERSAGLI FARMACOLOGICI NELLA RESISTENZA AI CHEMIOTERAPICI: FOCUS NELLA RIPROGRAMMAZIONE METABOLICA 49
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 46
In Vitro Cultured Melissa officinalis Cells as Effective Ingredient to Protect Skin Against Oxidative Stress, Blue Light, and Infrared Irradiations Damages 43
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy 43
Clinical evidence of interaction between nutraceutical supplementation and platinum-based chemotherapy 39
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 38
IDENTIFICAZIONE DI ESTRATTI NATURALI CON PROMETTENTE APPLICAZIONE IN FITOCOSMESI 38
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 38
The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance 37
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 33
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 32
Identification of extracts with antioxidant and anti-inflammatory activity in in vitro models 32
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 31
Curcumin and Cisplatin as new chemotherapeutic compounds in order to overcome cisplatin resistance 31
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 29
Natural compounds as metabolic modulators in resistant cancer cells models 29
Quercetin and Cisplatin combined treatment alter cell cycle and sensitize resistant cancer cell lines 29
UN NAFTOCHINONE ESTRATTO DALLA PIANTA PLUMBAGO ZEYLANICA L. INDUCE MORTE CELLULARE DELLE CELLULE RESISTENTI AL CISPLATINO 27
Natural compounds as metabolic modulators in resistant cancer models 26
VALIDAZIONE IN VITRO DI UNA COMBINAZIONE DI SERENOA REPENS E URTICA DIOICA PER LA TERAPIA DELL'IPERPLASIA PROSTATICA BENIGNA 26
Novel Adenosine Triphosphate-Based Nutraceutical Formulation to Prevent Non-Steroidal Anti-Inflammatory Drug Enteric Cell Toxicity: Preliminary In Vitro Evidence 25
Natural compounds as possible modulators of lipid metabolism in cisplatin-resistant cancer cells 24
Natural compounds as metabolic modulators in resistant cancer cell models 23
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 22
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 21
Editorial: Metabolism Meets Function: The Multifaced Role of Metabolism in Cancer 21
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells 19
Letter to Editor on the paper entitled “Curcumin-Celecoxib: A synergistic and rationale combination chemotherapy for breast cancer” 19
Mitochondrial phenotyping of doxorubicin-resistant osteosarcoma cells 19
VALUTAZIONE DELL’ATTIVITA’ ANTI-INVECCHIAMENTO DELL’ESTRATTO AS PER APPLICAZIONE FITOCOSMETICA 18
CHARACTERIZATION OF MITOCHONDRIAL METABOLISM OF DOXORUBICIN-RESISTANT OSTEOSARCOMA CELLS 17
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 15
Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins 14
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 14
LETTER TO EDITOR - ASSESSMENT OF ACUTE AND SUB-ACUTE TOXICITY OF OLIVE POMACE IN FEMALE WISTAR RATS 11
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 7
Totale 1.278
Categoria #
all - tutte 5.571
article - articoli 3.325
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 127
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020175 5 4 6 0 2 1 60 14 27 38 14 4
2020/2021169 2 5 6 27 3 23 28 10 31 6 20 8
2021/2022326 4 59 9 17 9 40 17 21 44 3 13 90
2022/2023298 58 5 7 15 48 22 1 22 39 10 44 27
2023/2024293 25 43 43 30 19 51 33 31 10 8 0 0
Totale 1.278